Jointly provided by Association of Aids Care (ANAC) Partners for Advancing Clinical Education (PACE), and PlatformQ Health Education, LLC.

ACKNOWLEDGEMENT

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

DATE OF RELEASE/EXPIRATION

Wednesday, August 30, 2023 from 4:00-5:00pm ET

TARGET AUDIENCE

The educational design of this activity addresses the needs of infectious disease specialists, PCPs, NPs/PAs, nurses, pharmacists, case managers, patient navigators, and other HCPs involved in the care of patients living with HIV.

STATEMENT OF NEED/PROGRAM OVERVIEW

Heavily treatment‐experienced (HTE) people living with HIV (PLWH) have limited antiretroviral (ARV) options to support the achievement of treatment goals and are often unable to achieve virologic suppression. The challenge of treatment failure in HTE PLWH is multifaceted and requires clinicians to be familiar with factors that influence inadequate virologic suppression, including biological, cultural, and socioeconomic issues, so they can anticipate when patients are at higher risk of treatment failure.

Join an expert panel for an in-depth discussion of the guideline‐directed management of HTE PLWH, emerging agents that could improve virologic suppression, and culturally competent care for patients in BIPOC (Black, indigenous, or people of color) communities. Panelists will review the guidelines for formulating new and effective ARV regimens, along with long‐acting and novel agents that could improve HTE patient outcomes. Strategies will also be shared to deliver HIV care in a culturally appropriate manner that fosters respect, comfort, and engagement among patients.

Do you have patients with HIV from BIPOC communities who would benefit from education on treatment options and available support resources? Direct your patients to MedLive.com. to access the companion activity, “Elevating the Voice of Treatment‐Experienced Patients Living with HIV: Treatment Options and Self‐Advocacy in Patients from BIPOC Communities.”

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

• Describe the relationship between unique social determinants of health and suboptimal virologic suppression in heavily treatment‐experienced (HTE) patients from BIPOC communities
• Discuss approaches to ARV management of the HTE patient after treatment failure
• Assess the potential of long‐acting agents to achieve viral suppression in the HTE patient
• Integrate cultural sensitivity into care for HTE patients of BIPOC communities

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING EDUCATION

PACE designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CONTINUING PROFESSIONAL DEVELOPMENT

ANAC will provide 1.0 contact hour of NCPD for the successful completion of this event

ANAC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 60 minutes to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, or NCPD contact hours, participants must receive a score of 75% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

FACULTY AND DISCLOSURE OF CONFLICTS OF INTEREST

PACE and ANAC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE and ANCC requirements policy. PACE and ANAC are committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty	Disclosure of Financial Relationships
Sheldon D. Fields, PhD, RN, FNP-BC, AACRN, FAANP, FNAP, FAAN Associate Dean for Equity and Inclusion Research Professor Ross and Carol Nese College of Nursing The Pennsylvania State University First Vice President National Black Nurses Association, Inc.	No relevant financial relationships to disclose
Mamta K. Jain, MD, MPH, FIDSA Professor Infectious Diseases UT Southwestern Medical Center	Researcher: Gilead Sciences Inc. and Laurent Pharmaceuticals
Onyema Ogbuagu, MD, FACP, FIDSA Associate Professor of Medicine & Director, Antivirals and Vaccines Research Program Section of Infectious Diseases Yale School of Medicine	Consultant, Advisor, and Speaker: Gilead Sciences Inc., Janssen Pharmaceuticals, ViiV Healthcare

The PACE, PlatformQ Health Education, LLC and ANAC planners have no relevant financial relationship(s) to disclose with ineligible companies.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:

For additional information about the accreditation of this activity, please visit https://partnersed.com.

Technical Support:

For any technical issues or issues with your CME Certificate, please contact IDCareLive or IDCareLive at 877-394-1306 or at Support@ClinicalSeriesLive.com or Support@ClinicalSeriesLive.com.